Disallowance of drug manufacturers from restricting delivery of 340B prescription drugs continued, enforcement provided, and expiration date removed.

HF 3609 prevents drug manufacturers from restricting how 340B program drugs are delivered to participating hospitals and clinics. It adds enforcement by treating violations as deceptive trade practices, allowing the attorney general to take action. The bill permanently removes an expiration date (previously set for July 1, 2027), making these restrictions permanent. This directly affects safety-net healthcare providers that rely on the 340B program for discounted medications.